The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cellular immune dysfunction in immune thrombocytopenia (ITP)

På svenska

Author

Summary, in English

Over the past decades, a wealth of information has been reported about the pathogenic features of immune thrombocytopenia (ITP). To this day, however, it is unclear whether the immune abnormalities associated with ITP play causative roles in the disease or are secondary epiphenomena brought on by the inflammatory processes that are associated with the disorder. Like the majority of all autoimmune diseases, ITP is an organ-specific disease and abnormalities in immune cell types, such as antigen-presenting cells (APC), T cells and B cells have been shown to play some sort of role in the initiation and/or perpetuation of the disease. This review will discuss recent advances in understanding three immune cells important in ITP pathophysiology: APC, T cells and B cells, and will review how they interact with each other to initiate and perpetuate ITP, particularly the chronic form of the disorder. It will also focus on new data related to the genetics of the disorder and discuss relevant animal models of ITP.

Publishing year

2013-10

Language

English

Pages

10-23

Publication/Series

British Journal of Haematology

Volume

163

Issue

1

Document type

Journal article

Publisher

Wiley-Blackwell

Keywords

  • Animals
  • Antigen-Presenting Cells
  • B-Lymphocytes
  • Disease Models, Animal
  • Humans
  • Immunity, Cellular
  • Purpura, Thrombocytopenic, Idiopathic
  • Signal Transduction
  • T-Lymphocyte Subsets
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Status

Published

ISBN/ISSN/Other

  • ISSN: 0007-1048